Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jul 20;39(21):2321-2323.
doi: 10.1200/JCO.21.00760. Epub 2021 Jun 8.

Paving the Way for Long-Term Survival in Non-Small-Cell Lung Cancer

Affiliations
Editorial

Paving the Way for Long-Term Survival in Non-Small-Cell Lung Cancer

Jordi Remon et al. J Clin Oncol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Jordi RemonConsulting or Advisory Role: Pfizer, Bristol Myers Squibb, Boehringer Ingelheim, MSD Oncology, AstraZeneca, OSE ImmunotherapeuticsTravel, Accommodations, Expenses: Roche/Genentech, Inivata, OSE Immunotherapeutics, AstraZeneca Lizza E. L. HendriksConsulting or Advisory Role: Bristol Myers Squibb, Roche/Genentech, Lilly, Pfizer, Takeda, Boehringer Ingelheim, AstraZeneca, MSD, AmgenSpeakers' Bureau: MSD, MedtalksResearch Funding: Roche/Genentech, AstraZeneca, Boehringer IngelheimTravel, Accommodations, Expenses: Roche/GenentechOther Relationship: AstraZeneca, Roche/Genentech, GlaxoSmithKline, Novartis, Merck Serono, Takeda, BluPrint Oncology, Mirati Therapeutics, Janssen Oncology Benjamin BesseResearch Funding: AstraZeneca, Pfizer, Lilly, Onxeo, Bristol Myers Squibb, Inivata, AbbVie, Amgen, Blueprint Medicines, Celgene, GlaxoSmithKline, Sanofi, Takeda, Cristal Therapeutics, Daiichi Sankyo, Janssen Oncology, OSE Immunotherapeutics, BeiGene, Boehringer Ingelheim, Roche/Genentech, Tolero Pharmaceuticals, 4D Pharma, Aptitude Health, CergentisNo other potential conflicts of interest were reported.

Comment on

MeSH terms

LinkOut - more resources